ICCC

IMMUCELL CORP

ICCC·452525306·US·Common Stock·Healthcare - Biotechnology-Activist

ICCC (IMMUCELL CORP) is held by 20 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.7M), MORGAN STANLEY ($2.4M), RENAISSANCE TECHNOLOGIES LLC ($1.7M). Net institutional sentiment: Bullish.

20
Holders
(2 Elite)
$11.3M
Total Value
80% (15)
Consensus
12 buying - 3 selling
13F: Insider & Congress: Updated regularly
ICCC

Smart Money Verdict

View all
Loading verdict
Held by 20 funds
2 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Jun 22, 2026 · Activists Nov 20, 2025 · Congress none

InsiderTOte Boekhorst Paul Francis OlivierBuy $76KJun 18, 2026
InsiderBFBRIGHAM MICHAEL FExercise 25K shMar 20, 2026
InsiderBFBRIGHAM MICHAEL FTax 24K shMar 20, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
268,130(+3.0%)$2.7M0.0%+66.97%
27
Increased
233,910(+5.5%)$2.4M0.0%+76.40%
28
Increased
171,089(+12.7%)$1.7M0.0%+74.00%
29
Unchanged
135,267$1.4M0.0%+79.36%
0
Increased
72,270(+9.9%)$726,4850.0%+83.60%
18
Increased
58,452(+4.3%)$587,4420.0%+59.32%
25
Increased
40,503(+13.5%)$407,0550.0%+65.55%
18
Decreased
37,766(-11.5%)$379,5480.0%+69.83%
0
Unchanged
24,354$244,7580.0%+74.65%
0
Increased
22,860(+25.7%)$229,7440.0%+96.46%
19
New
15,751$158,2980.0%+6.97%
34
New
15,415$154,9210.0%+6.97%
31
Decreased
14,721(-64.6%)$147,9460.0%+113.27%
0
New
12,000$120,6000.0%+6.97%
30
Decreased
1,000(-10.2%)$10,0500.0%+117.80%
0
Unchanged
391$3,9290.0%+108.74%
0
New
160$1,6080.0%+6.97%
17
New
30$3020.0%+6.97%
17
Unchanged
19$1860.0%+121.65%
0
Unchanged
1$70.0%+111.38%
0

Showing 1-20 of 20

ICCCICCCIMMUCELL CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used